At the Radiological Society of North America’s (RSNA) 2021
Annual Meeting, GE Healthcare unveiled around 60 innovative
technology solutions spanning the healthcare spectrum including
patient screening, diagnostics, therapy planning, guidance, and
monitoring. Amidst a global pandemic and mounting pressure on the
industry, the company accelerated innovations underpinned by
artificial intelligence (AI) and digital solutions to help
transform healthcare delivery, making it easier and more efficient
for clinicians and health systems, and more personalized and
precise for patients.
The pandemic exposed the fragility of the global healthcare
system, creating an urgent need for technology and solutions that
help clinicians manage seriously ill COVID-19 patients, advanced
diseases – such as cancer and heart disease – a backlog in
non-urgent care, and an ageing population, while battling burnout
and workforce shortages.
With these circumstances in mind, GE Healthcare is proud to
introduce technologies and solutions at #RSNA21 that help
healthcare systems:
- Increase efficiency and productivity;
- Reduce clinician burnout;
- Empower clinicians with AI and analytics when, where and how
they need it;
- Create a more resilient and sustainable healthcare industry;
and
- Increase access to care.
“Our goal is to make healthcare more human by breaking down
barriers so clinicians can work at the top of their game,
healthcare systems can operate more efficiently, and patients can
get the best and most personalized care possible,” said Kieran
Murphy, president & CEO, GE Healthcare. “Healthcare is at a
turning point and at GE Healthcare we are using our clinical
expertise and know-how to deliver innovative technologies and
solutions that help solve healthcare’s most pressing problems,
advance precision health and improve patient lives.”
Transforming healthcare through imaging technologies and
digital offerings
Over the last year and a half, the industry has embraced
technological innovation. What was once considered “futuristic” is
now fundamental. In an environment where clinical expertise,
regulatory know-how and speed matter, GE Healthcare rose to the
challenge. Working alongside clinicians and care teams to
understand the most pressing needs of radiologists and hospital
administrators, the company innovated new solutions, leveraging its
healthcare-specific intelligence platform, Edison, to help
providers achieve greater efficiency, reduce errors, increase speed
to appropriate treatments, and increase access to care.
To this end, GE Healthcare developed the following new
AI-powered, automated and data-driven solutions to help encourage
greater diagnostic confidence, ease the burden of care and improve
workflow for healthcare systems around the world:
- SIGNA Heroi is named for our heroes on the frontlines,
who continue to care for seriously ill patients as well as a
backlog in non-urgent care – all the while battling burnout and
workforce shortages. The new 3.0T MRI system offers new workflows
and AIR Recon DL enhancements designed to help our heroes on the
frontlines address some of today’s most pressing healthcare needs:
enhanced productivity, patient comfort, and sustainabilityii.
- SIGNA Artist Evoiii enables healthcare systems to
modernize their legacy 1.5T narrow 60 cm bore MR systems to 1.5T,
70 cm bore systems, accommodating more patients of different shapes
and sizes. Furthermore, the company’s patented flexible AIR Coils
design and AIR Recon DL image reconstruction help provide clearer,
sharper and more detailed images faster – enabling shorter patient
setup times and reducing table time.
- Revolution Apex platformiv provides exceptional image
quality and low dose scanning for routine and challenging cases in
many care areas with optimized clinical capabilities, built-in
scalability and upgradability options.
- Allia Platform is designed to enhance user experience,
improve workflow efficiency and increase the adoption of advanced
image guidance in daily practice – all important factors in today’s
constrained healthcare environment. In addition to personalizing
the Interventional or hybrid operating room with just one click of
the user interface, leveraging the Edison platform, the system also
harnesses the power of AI with AutoRightv – an advanced AI-based
interventional image chain – and Liver ASSIST Virtual
Parenchymavi,vii– a 3D visualization software solution designed to
provide AI-based virtual parenchymography to help clinicians
simulate injections dynamically and perform liver embolization
procedures with confidence.
- AMX Navigate represents GE Healthcare’s latest in
portable x-ray technology with a new Zero Click Exam workflow
solution and power-assisted Free Motion telescoping column to
reduce lift force by an estimated 70 percentviii, helping to
decrease X-ray technologist strain . The rugged reliability of the
AMX Navigate helps ensure it is ready to perform at the bedside of
the patient.
- Critical Care Suite 2.0 offers a collection of AI
algorithms embedded on a mobile x-ray device for case
prioritization, automated measurements, and quality control. For
the past year, the suite’s AI algorithm to help clinicians assess
Endotracheal Tube (ETT) placements has helped clinicians care for
an influx of critically ill COVID-19 patients who required
ventilation under the FDA COVID-19 imaging guidance. Now, Critical
Care Suite 2.0 has received full Food and Drug Administration (FDA)
510(k) clearance.
- Vscan Air provides clinicians with quick insights at the
point of care at a time when they need it most. This wireless and
pocket-sized ultrasound device provides exceptionally clear image
quality, whole-body scanning capabilities, and intuitive software -
all in the palm of the clinician’s hand. A dual-probe enables
whole-body scanning – with the flip of the wireless dual probe (for
deep and shallow scanning) and a push of a button to capture
images. Vscan Air offers a high-performance ultrasound machine in a
lightweight, portable device designed to improve patient experience
and access to ultrasound technology – involving patients by sharing
real-time image sharing as simple as see, snap, send.
- Enterprise Imaging in the Cloud delivers the power of
technology in a smart, digital ecosystem giving radiologists easy
and seamless access to GE Healthcare’s latest AI-based tools, data
and intelligent technology for visualization, diagnostics and
workflow as well as third party algorithms – from anywhere,
anytimeix,x. The solution is cloud-based, enabling healthcare
systems to manage upgrades instantly and digitally, with little to
no new hardware or on-site IT team required.
- Digital Expert Access is a real-time virtual
collaboration solution that is integrated into imaging devices.
With imaging experts in short supply and high demand and imaging
moving beyond hospital campuses, Digital Expert Access allows
sharing of expertise, best practices, and in-the-moment advice, as
well as remote console control – all from a distance.
- ulrichINJECT CT Motion uses automated syringeless
technology to support workflow efficiencies. The injector, now
approved with RIS/PACS integration, removes the need for manual
syringe filling which may minimize examination preparation time and
minimize contrast media waste.
A partner of choice creating and investing in new
possibilities for the healthcare industry
As innovators, integrators and clinical experts, GE Healthcare
is aligning its products and solutions across care pathways, such
as oncology, to create end-to-end solutions.
The company is working with industry leaders, such as SOPHiA
GENETICS, to deliver on the promise of integrated cancer care by
bringing insights across multiple diagnostic modalities with the
goal of better targeting and matching treatments to each patient’s
cancer type, helping to ensure more effective and personalized
treatment. Through the acquisition of Zionexa, the company is
advancing precision diagnostics and impacting clinical care by
commercializing innovative molecular imaging agents.
Furthermore, GE Healthcare offers deep industry expertise, an
ability to merge clinical and data science and a breadth of
solutions across pharmaceutical diagnostics, cyclotrons, chemistry
synthesis, PET/CT, PET/MR, nuclear medicine, advanced digital
solutions, and pharmaceutical partnerships – all to help clinicians
enhance patient care from discovery to diagnosis to treatment.
Using input from clinical partners, GE Healthcare has designed
technologies and digital solutions to keep up with the
ever-changing challenges that exist in the imaging world. The
Revolution Apex platform, for example, is designed with advanced
technologies intended to:
- Support one-beat cardiac imaging with motion management;
- Update their service line from a 40 mm detector and 0.28 second
rotation speed up to a 160 mm detector and 0.23 second per rotation
speed (FDA 510(k) pending) xi,xii ; and
- Reduce contrast dose up to 33% potentially.
“I'm a fan of the new Apex [platform] system and all the
possibilities around it. For us, it's a big win,” said Johan de
Mey, MD, PhD, Chair of Radiology at the Universitair Ziekenhuis,
Brussels, Belgium. “In the past, we kept machines as long as
possible, and we upgraded them with software. But if the hardware
was obsolete, we removed it from the hospital. With the Apex, we
have a platform with the latest technology and can easily upgrade
as our clinical practice evolves.”
Altogether, GE Healthcare is a partner of choice to thousands of
healthcare providers, medical technology innovators, and digital
start-ups around the world.
About GE Healthcare:
GE Healthcare is the $17 billion* healthcare business of GE
(NYSE: GE). As a leading global medical technology, pharmaceutical
diagnostics and digital solutions innovator, GE Healthcare enables
clinicians to make faster, more informed decisions through
intelligent devices, data analytics, applications and services,
supported by its Edison intelligence platform. With over 100 years
of healthcare industry experience and around 47,000 employees
globally, the company operates at the center of an ecosystem
working toward precision health, digitizing healthcare, helping
drive productivity and improve outcomes for patients, providers,
health systems and researchers around the world. On November 9,
2021, GE announced plans to spin-off GE Healthcare to create a
pure-play company at the center of precision health in early
2023.
Follow us on Facebook, LinkedIn, Twitter, and Insights for the
latest news, or visit our website www.gehealthcare.com for more
information.
*Excluding BioPharma
i SIGNA™ Hero is 510(k) pending at FDA. Not yet CE marked. Not
available for sale in the United States or the EU. Not commercially
available in all markets. ii AIR Recon DL 3D and PROPELLER is
510(k) pending at the FDA. Not CE marked. Not available for sale in
the United States or EU. Not commercially available in all markets.
iii SIGNA Artist Evo is 510(k) pending with the US FDA. Not yet CE
Marketed. Not available for sale in the United States or EU. Not
commercially available in all markets. iv GE Healthcare’s
Revolution Apex platform is FDA 510(k) cleared and not available
for sale in all countries. v AutoRight refers to intelligent image
chain features of GEHC’s Interventional x-ray systems, from image
acquisition to image processing and display. vi Liver ASSIST
Virtual Parenchyma is 510(k) cleared at FDA and CE Marked. Not
available for sale in all countries. vii Liver ASSIST Virtual
Parenchyma solution includes Hepatic VCAR and FlightPlan for Liver
with Parenchyma Analysis option and requires AW workstation with
Volume Viewer, Volume Viewer Innova, Vision 2, VesselIQ Xpress,
Autobone Xpress. These applications are sold separately. FlightPlan
for Liver with Parenchyma Analysis option may not be available for
sale in all countries. viii GE Data on File. The lift force
reduction is based upon the average lift force for the AMX Navigate
of 11.0 N as compared to the Optima XR240amx average lift force of
58.3 N. ix Anywhere the Internet is available. x Cloud deployment
currently only available in USA. xi Scalability and upgradability
are subject to the availability and compatibility of new
capabilities and products. xii 0.23sec and 19.5msec are 510k
pending and not available for sales in all countries. 19.5msec
effective temporal resolution is achieved by a 6x improvement of
motion-blur reduction while maintaining high spatial resolution as
demonstrated in cardiac phantom testing. The reduction in motion
artifacts is comparable to a 0.039 equivalent gantry rotation speed
with effective temporal resolution of 19.5 msec, as demonstrated in
mechanical and mathematical phantom testing.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211128005218/en/
Jennifer Fox jennifer.r.fox@ge.com 414-530-3027
General Electric (NYSE:GE)
過去 株価チャート
から 2 2024 まで 3 2024
General Electric (NYSE:GE)
過去 株価チャート
から 3 2023 まで 3 2024